The value of the UroVysion® FISH assay in the risk-stratification of patients with "atypical urothelial cells" in urinary cytology specimens.
Renu K VirkSchuharazad AbroJulianne Muus Martinez de UbagoStefan E PambuccianMarcus L QuekEva M WojcikSwati MehrotraGrazina U ChattGüliz A BarkanPublished in: Diagnostic cytopathology (2017)
U-FISH allows risk stratification in patients with AUC. However, its usefulness is diminished by the high false-positive rate, making it important to interpret U- FISH results in the patient's clinical context. Diagn. Cytopathol. 2017;45:481-500. © 2017 Wiley Periodicals, Inc.